Healthcare Services

A key trend shaping the Guillain-Barre Syndrome Market involves the Advancing Therapeutic Innovations For Improved Patient Outcomes

April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Large Is The Guillain-Barre Syndrome Market Projected To Become By 2030 Based On Its 2026 Valuation?

The guillain-barre syndrome market has witnessed robust expansion in recent years. It is anticipated to increase from $0.64 billion in 2025 to $0.67 billion in 2026, achieving a compound annual growth rate (CAGR) of 5.6%. This historical growth can be ascribed to improved recognition of autoimmune neurological conditions, the expansion of hospital-based neurology departments, increased availability of immunotherapy treatments, a rise in post-infectious complication cases, and better critical care infrastructure.

The guillain-barre syndrome market is expected to show robust expansion over the next few years. It is predicted to reach $0.83 billion by 2030, growing at a compound annual growth rate (CAGR) of 5.4%. This anticipated growth during the forecast period stems from increased funding in neurology research, a rising demand for advanced immunomodulatory therapies, the expansion of specialized rehabilitation services, wider adoption of digital neurological assessment tools, and a heightened focus on early intervention strategies. Significant trends for the forecast period include the increasing utilization of intravenous immunoglobulin therapies, a rise in the adoption of plasma exchange procedures, a growing emphasis on early neurological diagnosis, the expansion of specialized neurology care centers, and enhanced monitoring of autoimmune neurological disorders.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21198&type=smp

Which Market Drivers Are Supporting The Expansion Of The Guillain-Barre Syndrome Market?

The expanding threat of immunological diseases is anticipated to boost the growth of the guillain-barre syndrome market in the future. Immunological diseases are characterized by an overactive, underactive, or misdirected immune system, leading to conditions such as autoimmune disorders, allergies, or immunodeficiencies. These diseases are on the rise due to factors like environmental shifts, lifestyle choices, enhanced diagnostic methods, and genetic predispositions. Immunological diseases can lead to guillain-barré syndrome by initiating an autoimmune reaction where the body’s immune system mistakenly targets peripheral nerves, resulting in inflammation and nerve damage. For instance, in July 2024, a report from the Switzerland-based Joint United Nations Programme on HIV/AIDS (UNAIDS) indicated that by the close of 2022, approximately 39.5 million people globally were living with HIV, with 1.3 million new infections and 630,000 AIDS-related deaths recorded that year. In 2023, the worldwide population living with HIV grew to around 39.9 million. Hence, the increasing prevalence of immunological diseases is propelling the guillain-barre syndrome market.

What Segment Groups Are Identified Within The Guillain-Barre Syndrome Market?

The guillain-barre syndrome market covered in this report is segmented –

1) By Type: Acute Inflammatory Demyelinating Polyneuropathy (AIDP), Miller Fisher Syndrome (MFS), Acute Motor Axonal Neuropathy (AMAN)

2) By Therapeutics: Intravenous Immunoglobulin (IVIG), Plasma Exchange, Other Therapeutics

3) By End User: Hospitals, Specialty Neurology Clinics, Rehabilitation Centers, Home Healthcare Settings

Subsegments:

1) By Acute Inflammatory Demyelinating Polyneuropathy (AIDP): Classical AIDP, AIDP with Autonomic Involvement

2) By Miller Fisher Syndrome (MFS): Classical MFS, MFS With Ataxia, MFS With Ophthalmoplegia

3) By Acute Motor Axonal Neuropathy (AMAN): Classical AMAN, AMAN with Respiratory Involvement

What Industry Trends Are Redefining The Guillain-Barre Syndrome Market?

Major companies operating in the guillain-barre syndrome market are prioritizing the development of innovative drugs, such as monoclonal antibodies, to boost treatment efficacy, address unmet clinical requirements, and expand their market presence. Monoclonal antibodies are proteins engineered in laboratories designed to target specific antigens, which helps in modulating immune responses and improving therapeutic outcomes. For instance, in October 2023, Annexon Inc., a US-based biopharmaceutical company, obtained orphan drug designation from the European Medicines Agency (EMA) for its drug ANX005 for the treatment of guillain-barre syndrome (GBS). This drug is a monoclonal antibody specifically targeting C1q, which has shown early improvements in muscle strength and a reduced need for ventilation compared to IVIg, thus representing a significant therapeutic advancement.

Which Companies Hold Significant Positions In The Guillain-Barre Syndrome Market?

Major companies operating in the guillain-barre syndrome market are Pfizer Inc., Roche AG, AstraZeneca PLC, GSK plc, Takeda Pharmaceutical Company Limited, Merck & Co. Inc., Baxter International Inc., Biogen Inc., Horizon Therapeutics, Octapharma AG, Kedrion S.p.A., CSL Behring, Hansa Biopharma AB, Annexon Inc., Immunovant Inc., UCB S.A., Alexion Pharmaceuticals, Argenx SE, Grifols S.A., LFB S.A

Read the full guillain-barre syndrome market report here:

https://www.thebusinessresearchcompany.com/report/guillain-barre-syndrome-global-market-report

How Is The Guillain-Barre Syndrome Market Distributed Across Key Geographic Regions?

North America was the largest region in the guillain-barre syndrome market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the guillain-barre syndrome market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Guillain-Barre Syndrome Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=21198&type=smp

Browse Through More Reports Similar to the Global Guillain-Barre Syndrome Market 2026, By The Business Research Company

Narcolepsy Global Market Report

https://www.thebusinessresearchcompany.com/report/narcolepsy-global-market-report

Progressive Ataxia And Weakness Disorders Global Market Report

https://www.thebusinessresearchcompany.com/report/progressive-ataxia-and-weakness-disorders-global-market-report

Rare Neurological Disease Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/rare-neurological-disease-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795